Characterization of SCCmec, Spa Types and Multidrug Resistant of Methicillin-Resistant Staphylococcus aureus Isolates

Mojtaba Moosavian1,2, Paria Baratian Dehkordi2, Mohammad Hashemzadeh1,2

  • 1Infectious and Tropical Diseases Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

Abstract

Insights

This study characterized methicillin-resistant Staphylococcus aureus (MRSA) in Iran, revealing significant multidrug resistance (MDR) and extensive spa type diversity. Early detection of resistant MRSA strains is crucial for combating antimicrobial resistance.

Area of Science:

  • Clinical Microbiology
  • Infectious Diseases
  • Molecular Epidemiology

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) is a major healthcare-associated pathogen.
  • Molecular typing is essential for investigating MRSA outbreaks.
  • Characterizing MRSA isolates aids in understanding resistance patterns.

Purpose of the Study:

  • To characterize SCCmec types, spa types, and multidrug resistance of MRSA isolates in Ahvaz, Iran.
  • To identify common MRSA strains and their resistance profiles.
  • To assess the diversity of MRSA in a specific geographic region.

Main Methods:

  • Phenotypic methods and mecA gene detection identified 50 MRSA isolates.
  • Antibiotic resistance profiling and SCCmec typing were performed using disc diffusion and PCR.
  • spa typing utilized PCR-sequencing and high-resolution melting (HRM) analysis.

Main Results:

  • MRSA isolates showed highest sensitivity to vancomycin and linezolid, lowest to clindamycin.
  • 78% of isolates were multidrug-resistant (MDR), and 22% were extensively drug-resistant (XDR).
  • SCCmec type III was prevalent; 10 spa types were identified, with t037 and t030 being most common.

Conclusions:

  • Significant spa type variation exists among MRSA isolates, impacting treatment strategies.
  • Early detection of MDR, XDR, and potentially pandrug-resistant (PDR) MRSA is critical.
  • Clinical microbiology labs must prioritize detecting resistant MRSA strains to combat antimicrobial resistance.